beta-catenin antibody | knockout validation | Santa Cruz sc-7963
DOI
//dx.doi.org/10.13070/ko.en.7.2101
Date
2017-01-22

This is a knockout-validated antibody summary, based on the publication "β-Catenin C-terminal signals suppress p53 and are essential for artery formation", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

beta-catenin antibody | knockout validation | Santa Cruz sc-7963 figure 1
Figure 1. Western blot analysis of the indicated proteins in control (Ad-GFP) and β-catenin-KO (Ad-Cre) mouse aortic SMCs. From [1].
Antibody information

Mouse monoclonal IgG1 (kappa light chain)

Company: Santa Cruz

Antibody: beta-catenin

Catalog number: sc-7963

Summary: Mouse monoclonal IgG1 (kappa light chain) against amino acids 680-781 mapping at the C-terminus of β-catenin of human origin. Recommended for detection of β-catenin of human, mouse, and rat by western blot, immunoprecipitation, immunofluorescence, immunohistochemistry (paraffin) and ELISA.

Validation Method

Western blot | Immunohistochemistry | Immunocytochemistry

Sample

WB: Control and beta-catenin-KO mouse aortic smooth muscle cells. Whole-cell protein lysates were extracted using RIPA buffer (50 mM Tris-HCL pH 7.4, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 150 mM NaCl) with protease inhibitors (Complete, Roche). IHC: Control and smooth muscle-specific beta-catenin knockout mouse embryos. Embryos were fixed overnight with 4% formaldehyde and embedded in paraffin for sectioning. ICC: Control and beta-catenin-KO mouse aortic smooth muscle cells. Cells were fixed with cold methanol.

Blocking agent

WB: TBST (Tris pH 8.0, NaCl 150 mM, 0.1% Tween 20) with 4% (w/v) non-fat milk or BSA.

IHC: 2% bovine serum albumin (BSA)/10% normal serum (same species of secondary antibody) and avidin-blocking solution (Vector) in phosphate-buffered saline (PBS).

ICC: 0.3% Triton X-100, 2% BSA and 5% normal serum (same species as secondary antibody) in PBS.

Primary incubation

WB: 1:500 dilution at 4 °C overnight.

IHC: 1:250 dilution in 2% BSA/10% normal serum and biotin-blocking solution (Vector) in PBS.

ICC: 1:50 dilution in blocking solution.

Secondary incubation

WB: horseradish peroxidase-conjugated secondary antibodies.

IHC: 1:500 dilution biotinylated secondary antibody (Vector).

ICC: fluorochrome-conjugated secondary antibodies (Molecular Probes) in blocking solution.

Detection

WB: chemiluminescence (ECL, GE Healthcare).

IHC: ABC reagent (Vector PK-6100) and DAB/substrate/chromogen system (Dako K3467). Images were acquired with a digital microscope (COOLSCOPE, Nikon).

ICC: Axio Observer.Z1 microscope (Zeiss).

Disclaimer

If the antibody described in this summary is a polyclonal antibody, since polyclonal antibodies are of limited quantity, please inquire the supplier whether any current polyclonal antibody with the same catalog number is exactly the same as the one described in this summary. Sometimes, different bleeds or different animals are used, usually with a different lot number. In such cases, the result in this summary may not apply to the new antibody with the same catalog number.

References
  1. Riascos-Bernal D, Chinnasamy P, Cao L, Dunaway C, Valenta T, Basler K, et al. β-Catenin C-terminal signals suppress p53 and are essential for artery formation. Nat Commun. 2016;7:12389 pubmed publisher